News Digging > News > WSJ News Exclusive | Wall Street Backs New Class of Psychedelic Drugs
WSJ News Exclusive | Wall Street Backs New Class of Psychedelic Drugs
WSJ News Exclusive | Wall Street Backs New Class of Psychedelic Drugs,The psychedelic-therapy industry is getting a reality trip as investors and startups focus on treatments that will cost less time and money.

WSJ News Exclusive | Wall Street Backs New Class of Psychedelic Drugs

The psychedelic-therapy industry is getting a reality trip as investors and startups focus on treatments that will cost less time and money.